MI4 VM LLC Information

MI4 is an independent consulting and strategic advisory group specializing in molecular imaging, theranostics, radiopharmaceutical therapy, and precision oncology. We help organizations evaluate opportunities, develop programs, and translate clinical innovation into sustainable operations. Founded by Joseph R. Osborne, MD, PhD, and Manuel Paris, MI4 combines scientific and clinical expertise with executive leadership, business strategy, financial planning, and operational execution. Our advisory capabilities include: • Strategy & Program Development: Market assessments, feasibility studies, service-line strategy, business planning, and growth opportunities. • Molecular Imaging & Theranostics: Diagnostic and therapeutic program development, clinical pathways, and multidisciplinary integration. • Technology & Partnerships: Independent technology and vendor evaluation, strategic partnerships, and contracting strategy. • Operations & Financial Planning: Financial modeling, staffing, capacity planning, workflow design, and implementation readiness. • Research & Innovation: Clinical research strategy, emerging radiopharmaceuticals, industry collaboration, and translational opportunities. • Physician Education & Training: PET/CT interpretation training for radiologists, molecular imaging education, and emerging theranostic applications. MI4 supports health systems, physician groups, imaging organizations, and life sciences companies through focused advisory engagements and ongoing strategic partnerships. Our independent, multidisciplinary perspective helps clients assess investment decisions, navigate evolving technologies, and move from strategic planning to practical implementation. We bridge scientific innovation and healthcare strategy to advance sustainable clinical programs, organizational growth, and patient access. Inquiries: Message MI4 on LinkedIn